Abstract:Objective: To observe the expression of the Receptor of Advanced glycation end products (RAGE) in asthmatic rats, and explore the intervention of Roxithromycin. Methods: A total of 18 Specific Pathogen Free-class Brown Norway male rats were randomly divided into control group, asthma model group and Roxithromycin group, with 6 rats in each group. The asthmatic model was sensitized by intraperitoneal injection of Ovalbumin (OVA)+Al(OH)(3), and challenged with OVA. Rats in Roxithromycin group were given Roxithromycin 30 mg/kg 30 minutes before each challenge. Rats in control group and asthma model group were treated with equal volume of saline. The concentrations of RAGE and interleukin (IL)-4 in serum and bronchoalveolar lavage fluid (BALF) were measured by enzyme-linked immunosorbent (ELISA); the pathological changes of lung tissues were observed by HE-staining; the thickness of airway wall and airway smooth muscle were measured by Image-Pro Plus; the relative expression of RAGE in lung tissues were detected by Western blot. Results: In asthma model group, the concentrations of RAGE and IL-4 in the serum and BALF were obviously higher than those in control group [(494±32) vs (327±45) ng/L; (32.4±5.8) vs (13.1±2.9) ng/L; (553±38) vs (399±56) ng/L; (37.8±3.4) vs (19.4±2.5) ng/L] (all P<0.01); in Roxithromycin group, the concentrations of RAGE and IL-4 in the serum and BALF were obviously lower than those in asthma model group [(438±18) vs (494±32) ng/L; (22.8±6.0) vs (32.4±5.8) ng/L; (444±42) vs (553±38) ng/L; (25.6±4.5) vs (37.8±3.4) ng/L] (all P<0.05). In asthma model group, the bronchial wall was thickened, the lumen was narrow, the mucosal wrinkles were significantly increased, edema appeared under the mucosa, and a large number of inflammatory cells infiltrated and aggregated in the bronchi, perivascular and alveolar spaces; the thickness of airway wall and airway smooth muscle were significantly increased than those in control group (P<0.01); in Roxithromycin group, airway inflammation and remodeling were alleviated compared with those in asthma model group (P<0.05). In asthma model group, the expression of RAGE in lung tissues were significantly increased than those in control group (P<0.01); in Roxithromycin group, the expression of RAGE were significantly decreased than those in asthma model group (P<0.01). There were positive correlations between the expression of RAGE and IL-4 in BALF and serum (r=0.782, 0.804, all P<0.01); there were positive correlations between RAGE and total white cell counts, eosinophil counts, smooth muscle thickness (r=0.897, 0.927, 0.860, all P<0.01). Conclusions: The increasing of RAGE in asthmatic rats are positively correlated with airway inflammation and airway remodeling. Roxithromycin may inhibit the development of asthma by reducing the expression of RAGE.

RAGE mediates airway inflammation via the HDAC1 pathway in a toluene diisocyanate-induced murine asthma model

RAGE Mediates Β-Catenin Stabilization Via Activation of the Src/p-Cav-1 Axis in a Chemical-Induced Asthma Model

JNK modulates RAGE/β-catenin signaling and is essential for allergic airway inflammation in asthma

[Receptor for Advanced Glycation End Products Upregulates MUC5AC Expression and Promotes Mucus Overproduction in Mice with Toluene Diisocyanate-Induced Asthma].

Phosphorylation of Low Density Lipoprotein Receptor-Related Protein 6 is Involved in Receptor for Advanced Glycation End Product-Mediated Β-Catenin Stabilization in a Toluene Diisocyanate-Induced Asthma Model

Bongkrekic acid alleviates airway inflammation via breaking the mPTP/mtDAMPs/RAGE feedback loop in a steroid-insensitive asthma model

Toluene diisocyanate-induced inflammation and airway remodeling involves autophagy in human bronchial epithelial cells

The Receptor for Advanced Glycation End Products is Required for Β‐catenin Stabilization in a Chemical‐induced Asthma Model

HMGB1 Binding to the RAGE Receptor Contributes to the Pathogenesis of Asthma

The HDAC10 instructs macrophage M2 program via deacetylation of STAT3 and promotes allergic airway inflammation

Transient Receptor Potential Ion Channels Mediate Adherens Junctions Dysfunction in a Toluene Diisocyanate-Induced Murine Asthma Model

Srage Alleviates Neutrophilic Asthma by Blocking HMGB1/RAGE Signalling in Airway Dendritic Cells

Phosphatidylinositol 3-kinases pathway mediates lung caspase-1 activation and high mobility group box 1 production in a toluene-diisocyanate induced murine asthma model.

HMGB1/RAGE Signaling Regulates Th17/IL-17 and Its Role in Bronchial Epithelial-Mesenchymal Transformation

Knockout of RAGE Ameliorates Mainstream Cigarette Smoke-Induced Airway Inflammation in Mice.

PTRF-IL33-ZBP1 signaling mediating macrophage necroptosis contributes to HDM-induced airway inflammation

[Expression of RAGE in Asthmatic Rats and the Intervention of Roxithromycin].

Phosphatidylinositol 3-Kinase Mediates Beta-Catenin Dysfunction Of Airway Epithelium In A Toluene Diisocyanate-Induced Murine Asthma Model

Blockade of Β-Catenin Signaling Attenuates Toluene Diisocyanate-Induced Experimental Asthma.

RAGE-ligands axis: A new 'driving force' for cigarette smoke-induced airway inflammation in COPD?

RAGE-mediated functional DNA methylated modification contributes to cigarette smoke-induced airway inflammation in mice